Fig. 2.
Fig. 2. Anti-inv16 antibody detection of CBFβ-SMMHC fusions. Flow cytometric detection of CBFβ-SMMHC using anti-inv16 Ab. The black trace represents isotype control. The gray trace represents anti-inv(16) Ab. (A and B) PN 13 and PN 21, respectively, demonstrating detection of type A fusion product; (C) PN 1 with type D fusion detected by anti-inv16 Ab; (D) PN 22 with novel CBFB-MYH11fusion; (E and F) PN 28 and PN 30 negative controls. Refer to Table 1and text for details.

Anti-inv16 antibody detection of CBFβ-SMMHC fusions. Flow cytometric detection of CBFβ-SMMHC using anti-inv16 Ab. The black trace represents isotype control. The gray trace represents anti-inv(16) Ab. (A and B) PN 13 and PN 21, respectively, demonstrating detection of type A fusion product; (C) PN 1 with type D fusion detected by anti-inv16 Ab; (D) PN 22 with novel CBFB-MYH11fusion; (E and F) PN 28 and PN 30 negative controls. Refer to Table 1and text for details.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal